Last updated on December 2018

Study To Compare Avelumab In Combination With Standard of Care Chemoradiotherapy (SoC CRT) Versus SoC CRT for Definitive Treatment In Patients With Locally Advanced Squamous Cell Carcinoma Of The Head And Neck (JAVELIN HEAD AND NECK 100)

Brief description of study

This is a phase 3 randomized, placebo controlled study to evaluate the safety and anti-tumor activity of Avelumab in combination with standard of care chemoradiation (SoC CRT) versus SoC CRT alone in front-line treatment of patients with locally advanced head and neck cancer.

Clinical Study Identifier: NCT02952586

Contact Investigators or Research Sites near you

Start Over

Pfizer Call Center

Herbert-Herman Cancer Center, Sparrow Health System
Lansing, MI United States
  Connect »